Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas

Cancer Genetics and Cytogenetics

Volumn 154, Issue 2, 2004, Pages 131-137

  Su, Wendy T ^a   Alaminos, Miguel ^b   Mora, Jaume ^b   Cheung, Nai Kong ^c   La Quaglia, Michael P ^a   Gerald, William L ^b  

^a Department of Surgery   (Italy)

^b Department of Pathology ^*

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 12Q; DNA MICROARRAY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE MAPPING; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; NEUROBLASTOMA; PRIORITY JOURNAL;

BRAIN NEOPLASMS; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 12; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; HUMANS; NEUROBLASTOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 5144225768     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2004.02.009     Document Type: Article

References (42)

1. Berthold F., Sahin K., Hero B., Christiansen H., Gehring M., Harms D., Horz S., Lampert F., Schwab M., and Terpe J. The current contribution of molecular factors to risk estimation in neuroblastoma patients Eur J Cancer 33 1997 2092 2097
2. Ambros P.F., Ambros I.M., Strehl S., Bauer S., Luegmayr A., Kovar H., Ladenstein R., Fink F.M., Horcher E., and Printz G. Regression and progression in neuroblastoma. Does genetics predict tumour behaviour? Eur J Cancer 31A 1995 510 515
3. Ikeda H., Iehara T., Tsuchida Y., Kaneko M., Hata J., Naito H., Iwafuchi M., Ohnuma N., Mugishima H., Toyoda Y., Hamazaki M., Mimaya J., Kondo S., Kawa K., Okada A., Hiyama E., Suita S., and Takamatsu H. Experience with international neuroblastoma staging system and pathology classification Br J Cancer 86 2002 1110 1116
4. Brodeur G.M., Azar C., Brother M., Hiemstra J., Kaufman B., Marshall H., Moley J., Nakagawara A., Saylors R., and Scavarda N. Neuroblastoma. Effect of genetic factors on prognosis and treatment Cancer 70 1992 1685 1694
5. Cheung N.K., Kushner B.H., LaQuaglia M.P., Kramer K., Ambros P., Ambros I., Ladanyi M., Eddy J., Bonilla M.A., and Gerald W. Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers Eur J Cancer 33 1997 2117 2120
6. Mora J., Cheung N.K., Chen L., Qin J., and Gerald W. Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional disease Cancer 91 2001 435 442
7. Mora J., Gerald W.L., Qin J., and Cheung N.K. Molecular genetics of neuroblastoma and the implications for clinical management: a review of the MSKCC experience Oncologist 6 2001 263 268
8. Mora J., Cheung N.K., Oplanich S., Chen L., and Gerald W.L. Novel regions of allelic imbalance identified by genome-wide analysis of neuroblastoma Cancer Res 62 2002 1761 1767
9. Corvi R., Savelyeva L., Amler L., Handgretinger R., and Schwab M. Cytogenetic evolution of MYCN and MDM2 amplification in the neuroblastoma LS tumour and its cell line Eur J Cancer 31A 1995 520 523
10. Corvi R., Savelyeva L., Breit S., Wenzel A., Handgretinger R., Barak J., Oren M., Amler L., and Schwab M. Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma Oncogene 10 1995 1081 1086
11. Corvi R., Savelyeva L., and Schwab M. Patterns of oncogene activation in human neuroblastoma cells J Neurooncol 31 1997 25 31
12. Van Roy N., Forus A., Myklebost O., Cheng N.C., Versteeg R., and Speleman F. Identification of two distinct chromosome 12-derived amplification units in neuroblastoma cell line NGP Cancer Genet Cytogenet 82 1995 151 154
13. Elkahloun A.G., Bittner M., Hoskins K., Gemmill R., and Meltzer P.S. Molecular cytogenetic characterization and physical mapping of 12q13-q15 amplification in human cancers Genes Chromosomes Cancer 17 1996 205 214
14. Reifenberger G., Reifenberger J., Ichimura K., and Collins V.P. Amplification at 12q13-14 in human malignant gliomas is frequently accompanied by loss of heterozygosity at loci proximal and distal to the amplification site Cancer Res 55 1995 731 734
15. Gisselsson D., Palsson E., Hoglund M., Domanski H., Mertens F., Pandis N., Sciot R., Dal Cin P., Bridge J.A., and Mandahl N. Differentially amplified chromosome 12 sequences in low- and high-grade osteosarcoma Genes Chromosomes Cancer 33 2002 133 140
16. Forus A., Bjerkehagen B., Sirvent N., Meza-Zepeda L.A., Coindre J.M., Berner J.M., Myklebost O., and Pedeutour F. A well-differentiated liposarcoma with a new type of chromosome 12-derived markers Cancer Genet Cytogenet 131 2001 13 18
17. Alaminos M., Mora J., Cheung N.K., Smith A., Qin J., Chen L., and Gerald W.L. Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma Cancer Res 63 2003 4538 4546
18. Argani P., Antonescu C.R., Illei P.B., Lui M.Y., Timmons C.F., Newbury R., Reuter V.E., Garvin A.J., Perez-Atayde A.R., Fletcher J.A., Beckwith J.B., Bridge J.A., and Ladanyi M. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents Am J Pathol 159 2001 179 192
19. Berner J.M., Forus A., Elkahloun A., Meltzer P.S., Fodstad O., and Myklebost O. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas Genes Chromosomes Cancer 17 1996 254 259
20. Reifenberger G., Ichimura K., Reifenberger J., Elkahloun A.G., Meltzer P.S., and Collins V.P. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets Cancer Res 56 1996 5141 5145
21. Ross R.A., Lazarova D.L., Manley G.T., Smitt P.S., Spengler B.A., Posner J.B., and Biedler J.L. HuD, a neuronal-specific RNA-binding protein, is a potential regulator of MYCN expression in human neuroblastoma cells Eur J Cancer 33 1997 2071 2074
22. Mora J., Gerald W.L., Qin J., and Cheung N.K. Evolving significance of prognostic markers associated with treatment improvement in patients with stage 4 neuroblastoma Cancer 94 2002 2756 2765
23. Fong C.T., White P.S., Peterson K., Sapienza C., Cavenee W.K., Kern S.E., Vogelstein B., Cantor A.B., Look A.T., and Brodeur G.M. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas Cancer Res 52 1992 1780 1785
24. Bown N., Cotterill S., Lastowska M., O'Neill S., Pearson A.D., Plantaz D., Meddeb M., Danglot G., Brinkschmidt C., Christiansen H., Laureys G., Speleman F., Nicholson J., Bernheim A., Betts D.R., Vandesompele J., and Van Roy N. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma N Engl J Med 340 1999 1954 1961
25. Caron H. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma Med Pediatr Oncol 24 1995 215 221
26. Maris J.M., Weiss M.J., Guo C., Gerbing R.B., Stram D.O., White P.S., Hogarty M.D., Sulman E.P., Thompson P.M., Lukens J.N., Matthay K.K., Seeger R.C., and Brodeur G.M. Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study J Clin Oncol 18 2000 1888 1899
27. Mischel P.S., Shai R., Shi T., Horvath S., Lu K.V., Choe G., Seligson D., Kremen T.J., Palotie A., Liau L.M., Cloughesy T.F., and Nelson S.F. Identification of molecular subtypes of glioblastoma by gene expression profiling Oncogene 22 2003 2361 2373
28. Jin C., Martins C., Jin Y., Wiegant J., Wennerberg J., Dictor M., Gisselsson D., Strombeck B., Fonseca I., Mitelman F., Tanke H.J., Hoglund M., and Mertens F. Characterization of chromosome aberrations in salivary gland tumors by FISH, including multicolor COBRA-FISH Genes Chromosomes Cancer 30 2001 161 167
29. Schmidt H., Taubert H., Wurl P., Kappler M., Lange H., Bartel F., Bache M., Holzhausen H.J., and Hinze R. Gains of 12q are the most frequent genomic imbalances in adult fibrosarcoma and are correlated with a poor outcome Genes Chromosomes Cancer 34 2002 69 77
30. Dei Tos A.P., Doglioni C., Piccinin S., Sciot R., Furlanetto A., Boiocchi M., Dal Cin P., Maestro R., Fletcher C.D., and Tallini G. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours J Pathol 190 2000 531 536
31. Pilotti S., Della Torre G., Mezzelani A., Tamborini E., Azzarelli A., Sozzi G., and Pierotti M.A. The expression of MDM2/CDK4 gene product in the differential diagnosis of well differentiated liposarcoma and large deep-seated lipoma Br J Cancer 82 2000 1271 1275
32. Elkahloun A.G., Krizman D.B., Wang Z., Hofmann T.A., Roe B., and Meltzer P.S. Transcript mapping in a 46-kb sequenced region at the core of 12q13.3 amplification in human cancers Genomics 42 1997 295 301
33. Freedman D.A., and Levine A.J. Regulation of the p53 protein by the MDM2 oncoprotein-thirty-eighth G.H.A. (Clowes Memorial Award Lecture) Cancer Res 59 1999 1 7
34. Freedman D.A., Wu L., and Levine A.J. Functions of the MDM2 oncoprotein Cell Mol Life Sci 55 1999 96 107
35. Sigalas I., Calvert A.H., Anderson J.J., Neal D.E., and Lunec J. Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer Nat Med 2 1996 912 917
36. Jankowski S.A., Mitchell D.S., Smith S.H., Trent J.M., and Meltzer P.S. SAS, a gene amplified in human sarcomas, encodes a new member of the transmembrane 4 superfamily of proteins Oncogene 9 1994 1205 1211
37. Su Y.A., Hutter C.M., Trent J.M., and Meltzer P.S. Complete sequence analysis of a gene (OS-9) ubiquitously expressed in human tissues and amplified in sarcomas Mol Carcinog 15 1996 270 275
38. Kimura Y., Nakazawa M., Tsuchiya N., Asakawa S., Shimizu N., and Yamada M. Genomic organization of the OS-9 gene amplified in human sarcomas J Biochem (Tokyo) 122 1997 1190 1195
39. Vigneron N., Ooms A., Morel S., Degiovanni G., and Van Den Eynde B.J. Identification of a new peptide recognized by autologous cytolytic T lymphocytes on a human melanoma Cancer Immun 2 2002 9
40. Marks P.W., Arai M., Bandura J.L., and Kwiatkowski D.J. Advillin (p92): a new member of the gelsolin/villin family of actin regulatory proteins J Cell Sci 111 1998 2129 2136
41. Won K.A., Schumacher R.J., Farr G.W., Horwich A.L., and Reed S.I. Maturation of human cyclin E requires the function of eukaryotic chaperonin CCT Mol Cell Biol 18 1998 7584 7589
42. Xin H., Woriax V., Burkhart W., and Spremulli L.L. Cloning and expression of mitochondrial translational elongation factor Ts from bovine and human liver J Biol Chem 270 1995 17243 17249